Global Fungal Infection Diagnosis Market Growth (Status and Outlook) 2024-2030

Global Fungal Infection Diagnosis Market Growth (Status and Outlook) 2024-2030

The global Fungal Infection Diagnosis market size is projected to grow from US$ 115 million in 2024 to US$ 258 million in 2030; it is expected to grow at a CAGR of 14.5% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Fungal Infection Diagnosis Industry Forecast” looks at past sales and reviews total world Fungal Infection Diagnosis sales in 2022, providing a comprehensive analysis by region and market sector of projected Fungal Infection Diagnosis sales for 2023 through 2029. With Fungal Infection Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Fungal Infection Diagnosis industry.

This Insight Report provides a comprehensive analysis of the global Fungal Infection Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Fungal Infection Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Fungal Infection Diagnosis market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Fungal Infection Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Fungal Infection Diagnosis.

Global key players of Fungal Infection Diagnosis include Era Biology, Dynamiker Biotechnology, Bio-Rad, Associates of Cape Cod, Zhanjiang A & C Biological, etc. The top five players hold a share over 61%. Asia-Pacific is the largest market, and has a share about 68%, followed by North America and Europe with share 15% and 10%, separately. In terms of product type, Galactomannan Test is the largest segment, occupied for a share of 55%. In terms of application, Hospital has a share about 80 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Fungal Infection Diagnosis market by product type, application, key players and key regions and countries.

Segmentation by Type:
Galactomannan Test
(1→3)-β-D Glucan Test

Segmentation by Application:
Hospital
Laboratory

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Galactomannan Test
(1→3)-β-D Glucan Test

Segmentation by Application:
Hospital
Laboratory

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Associates of Cape Cod
Bio-Rad
IMMY
Era Biology
Dynamiker Biotechnology
Zhanjiang A & C Biological
Xiamen Bioendo Technology
Zhanjiang Bokang Marine Biological
Fuzhou XinBei Biochemical Industrial
Zhuhai DL Biotech
Autobio Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.